Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CMPX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $183.69M
- EPS (TTM)
- -$0.39
- Dividend yield
- None
- 52-week range
- 0.829 – 6.88
- Day range
- 0.965 – 1.06
- Volume / Avg
- 2.79M / 4.08M
- Beta
- —
- Shares outstanding
- 180.09M
- Next earnings
- Nov 4, 2026
52-week range
CMPX stock today
Compass Therapeutics (CMPX) closed at $1.02 on Oct 7, up 2.19% (+$0.0219), versus the S&P 500's 0.22% decline. At this level, CMPX sits near the bottom of its 52-week range of $0.829 to $6.88: 85.2% below the high, set on Feb 3, 2026 and 23.0% above the low. CMPX is down 81.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 71.7%.
Compass Therapeutics has posted a net loss over the last twelve months (EPS of -$0.39), so its P/E ratio is not meaningful. Compass Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Compass Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.12
Compass Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DTILPrecision BioSciences Inc. | 6.25 | +0.81% | $172.51M | vs CMPX |
| IPHAInnate Pharma S.A. ADS | 1.52 | -4.40% | $169.78M | vs CMPX |
| CGENCompugen Ltd. | 2.15 | -3.15% | $203.66M | vs CMPX |
| CRDLCardiol Therapeutics Inc. Class A | 1.32 | +0.76% | $160.40M | vs CMPX |
| CHRSCoherus Oncology Inc. | 1.01 | -1.94% | $156.05M | vs CMPX |
| TARAProtara Therapeutics Inc. | 2.59 | +1.37% | $153.06M | vs CMPX |
| ALECAlector Inc. | 1.92 | +6.08% | $214.38M | vs CMPX |
| IVVDInvivyd Inc. | 0.7286 | -9.65% | $214.76M | vs CMPX |
Indexes, lists and sector
Compass Therapeutics stock FAQ
What is Compass Therapeutics's stock price today?
CMPX last traded at $1.02 as of Oct 7, 4:00 PM EDT, up 2.19% on the day. Prices are delayed at least 15 minutes.
When is Compass Therapeutics's next earnings date?
Compass Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.12.
What is the CMPX 52-week high?
The 52-week high for CMPX is $6.88 and the 52-week low is $0.829. The stock is currently 85.2% below its high.